Developer docs
API playgroundTry for free, no card

Search company profiles

Nunatak Biotech

Full company profile

uuid0002twe

Namestring
Nunatak Biotech
Legal namestring
Nunatak Biotech
Websiteurl
nunatakbio.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Nunatak Biotech is an Argentine biotechnology company founded in 2023 that designs biological crop inputs derived from extremophile microorganisms isolated from Antarctica and other polar environments. The company's core technology is a platform that combines microbiology with bioinformatics to characterize extremophile microbiomes and design functional microbial consortia capable of improving plant performance under abiotic stresses such as cold, salinity, and soil degradation. Its commercial product line is branded Yamana and comprises three SKUs: the core Yamana biological enhancer with a triple-action mechanism combining a microbial consortium, micronutrition, and organic amendment functioning as both biofertilizer and biostimulant; Yamana Cold, a microbial seed treatment built on the proprietary Pseudomonas fluorescens NB1 strain isolated from Antarctica for cold-stress tolerance in soybean, wheat, corn, and potato; and the forthcoming Yamana Terra, designed for plant establishment in saline and stressed soils.

The company serves large agribusinesses and farmers as its primary customer segment, with secondary segments in food and beverage companies seeking supply-chain resilience and in land restoration and remediation projects targeting degraded soils. Its go-to-market is enterprise field sales, with direct engagement on pilot programs and field-scale validation alongside a partner network of agricultural input companies; products are positioned as fully stackable with existing chemical seed treatments and compatible with other biological inputs to lower adoption friction. Pricing is not publicly disclosed.

Nunatak operates with a small team of approximately 1–10 employees led by four co-founders — Julia Mensa (CEO), Lucas Ruberto (R&D Head), Martha Martorell (COO), and Francisco Massot (CTO) — supported by a Science & Tech team, a Business team, partners, and an advisor. The company is privately held, headquartered in Argentina, has participated in at least four accelerator programs between 2024 and 2026 (including GRID EXPONENTIAL, SVG Ventures, Eatable Adventures, and Agrofood BIC), and reports no public revenue disclosures or patents in the source material.

Short descriptiontext

Nunatak Biotech is an Argentine biotech startup that develops microbial bioinputs derived from Antarctic extremophiles to improve crop performance under abiotic stress, serving agribusinesses, farmers, and land restoration projects through pilot-stage field sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBuenos Aires, Argentina
HQ citystring
Buenos Aires
HQ countrystring
Argentina
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
agricultural biological inputs, microbial seed treatments, soil restoration solutions, abiotic stress management, biofertilizer products
Industry3 codes
PRIMARYAFABAEAK
Biostimulants & Plant Health Biologicals (Microbial/Non-microbial)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
SECONDARYIMAEAEAG
Biofertilizers & Microbial Inoculants
SECONDARYAFABAEAM
Biological Formulation, Fermentation & Scale-Up Manufacturing
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
NAICS code2 codes
  • Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing3253
  • Pesticide and Other Agricultural Chemical Manufacturing32532
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Agricultural Biologicals
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Biological Seed Treatments
TypeOthers
Description

Sale of microbial seed treatment products (Yamana Cold, Yamana Terra) to farmers and agribusiness companies for improving crop establishment and performance under stress conditions. Products are sold as liquid seed treatments with low-dose efficiency.

nunatakbio.com
2Bioinputs for Land Restoration
TypeOthers
Description

Sale of biological solutions for land restoration and remediation projects targeting degraded soils and long-term soil-plant health rebuilding.

nunatakbio.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Yamana
Description

First biological enhancer product from Nunatak's platform designed for yield improvement and crop establishment. Includes Yamana Cold - a microbial seed treatment formulated with Pseudomonas fluorescens NB1 for cold stress conditions.

nunatakbio.com
+2 more records
Core offering1 text field

Nunatak Biotech develops and manufactures biological agricultural inputs (biofertilizers, biostimulants, and microbial seed treatments) derived from extremophile microorganisms sourced from Antarctica and other extreme environments. The company's products, marketed under the YAMANA brand, combine microbial consortia with micronutrition and organic amendments to improve crop tolerance to abiotic stresses such as cold, salinity, and soil degradation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 50% of irrigated land becomes salinized
+2 more records
Product overview1 text field

Nunatak Biotech offers a platform-based approach to biological solutions for agriculture and land restoration. Their flagship product line YAMANA includes YAMANA (core biological enhancer for crop establishment with triple-action mechanism: microbial consortium, micronutrition, and organic amendment), YAMANA Cold (microbial seed treatment for cold stress tolerance using Pseudomonas fluorescens NB1 isolated from Antarctica), and the upcoming Yamana Terra (biological solution for plant establishment in saline soils). All products leverage extremophile microorganisms from extreme environments to improve plant tolerance to abiotic stress.

Product and service2 records
1YAMANA
CategoryBiological crop enhancement
Description

YAMANA is a biological enhancer for crop establishment with a triple-action mechanism combining a microbial consortium, micronutrition, and an organic regenerator (amendment). It functions as both a biofertilizer and biostimulant, with modes of action including biological nitrogen fixation, phosphate solubilization, biofilm formation, and biocontrol of fungal phytopathogens. Target crops include wheat, barley, soybean, and pastures. Sold to agribusinesses and farmers.

2YAMANA Cold
CategoryBiological seed treatment
Description

YAMANA Cold is a microbial seed treatment formulated with Pseudomonas fluorescens NB1, a native strain isolated from Antarctica naturally adapted to thrive under cold stress. Applied before sowing, it promotes uniform germination and early crop establishment under low-temperature conditions, supporting soybean, wheat, corn, and potato crops. Fully stackable with chemical seed treatments and compatible with selected biological inputs. Sold to agribusinesses and farmers.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Accelerators
Strategic tierCoreTypeOthers
Description

Nunatak collaborates with accelerators as part of their ecosystem, having been selected by leading agrifood and climate innovation programs. They participated in 236+ international programs and accelerators.

nunatakbio.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Corporate partners collaborating with Nunatak in their ecosystem to transform agriculture and restore soils through biological solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Innovation hubs part of Nunatak's collaborative ecosystem for transforming agriculture and developing biological solutions.

4Research Institutions
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research institutions collaborating with Nunatak, supporting the scientific foundation of their extreme microbiome platform and product development.

nunatakbio.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

Accelerators that organized the event in Buenos Aires where Nunatak (along with EYWA and Cromodata) presented their ventures, aiming to bridge gender gaps in Latin America's venture capital ecosystem.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Argentine biotech developing extremophile (including Andean/Atacama-derived) microbial biofertilizers for stressed soils. Closest direct comparable to Nunatak: same Argentine origin, same extremophile-to-agriculture thesis, same broad-acre row crop focus.

2Bioceres
TypeBroad incumbent
Description

Argentina-based agricultural biotechnology company with biological-input adjacencies (including Rizobacter) and trait platforms (HB4). Larger incumbent that competes for the same Argentine/LATAM agribusiness customer base and validates the market for biological inputs in the region.

TypeDirect peer
Description

Spanish manufacturer of microbial biofertilizers and biostimulants (e.g., Mycoshell, Trichoderma-based products). Closely comparable in product category (microbial biostimulants/biofertilizers) and go-to-market (partner-driven distribution to agribusiness), though larger and more global.

TypeDirect peer
Description

US-based ag biotech commercializing microbial seed treatments and biostimulants (e.g., Indigo's biotrinsic portfolio) targeted at row crops. Directly competes in the microbial seed treatment category that YAMANA Cold targets.

TypeDirect peer
Description

US-based microbial nitrogen-fixation company whose products (ProveN, ProveN 40, ReturN) overlap with the biofertilizer/biostimulant mechanism of YAMANA. Comparable in targeting row crops with a microbial mode of action that supplements or replaces conventional nitrogen inputs.

TypeBroad incumbent
Description

Global microbial and enzyme powerhouse with a dedicated agriculture biological-input business. Broad incumbent in the same product category; does not specialize in extremophile-sourced consortia but sets the pricing and channel benchmark for microbial ag inputs.

TypeDirect peer
Description

US-based biological crop protection and input company using microbial discovery to develop agricultural products (e.g., Howler fungicide, AgBiomeLabs). Comparable as a microbial-discovery platform turned product company, with a similar biological-input go-to-market.

TypeDirect peer
Description

US-based company developing microbial and on-demand nutrient solutions for row crops. Comparable in product category (microbial + nutrient combination) and target customer (broad-acre agribusiness growers).

TypeDirect peer
Description

US-based microbial discovery and product company developing seed treatments and in-furrow biologicals. Comparable as a microbial-consortium platform company focused on row crop biological inputs.

TypeDirect peer
Description

US-based producer of microbial soil and seed treatments (e.g., Rhizo-L, Fungi-Act) targeting broad-acre crops. Comparable in offering microbial-based biological inputs and in working with agribusiness distribution channels.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nunatak Biotech

Agricultural Biologicalsnunatakbio.com

Nunatak Biotech is an Argentine biotech startup that develops microbial bioinputs derived from Antarctic extremophiles to improve crop performance under abiotic stress, serving agribusinesses, farmers, and land restoration projects through pilot-stage field sales.

What Nunatak Biotech does

Nunatak Biotech is an Argentine biotechnology company founded in 2023 that designs biological crop inputs derived from extremophile microorganisms isolated from Antarctica and other polar environments. The company's core technology is a platform that combines microbiology with bioinformatics to characterize extremophile microbiomes and design functional microbial consortia capable of improving plant performance under abiotic stresses such as cold, salinity, and soil degradation. Its commercial product line is branded Yamana and comprises three SKUs: the core Yamana biological enhancer with a triple-action mechanism combining a microbial consortium, micronutrition, and organic amendment functioning as both biofertilizer and biostimulant; Yamana Cold, a microbial seed treatment built on the proprietary Pseudomonas fluorescens NB1 strain isolated from Antarctica for cold-stress tolerance in soybean, wheat, corn, and potato; and the forthcoming Yamana Terra, designed for plant establishment in saline and stressed soils.

The company serves large agribusinesses and farmers as its primary customer segment, with secondary segments in food and beverage companies seeking supply-chain resilience and in land restoration and remediation projects targeting degraded soils. Its go-to-market is enterprise field sales, with direct engagement on pilot programs and field-scale validation alongside a partner network of agricultural input companies; products are positioned as fully stackable with existing chemical seed treatments and compatible with other biological inputs to lower adoption friction. Pricing is not publicly disclosed.

Nunatak operates with a small team of approximately 1–10 employees led by four co-founders — Julia Mensa (CEO), Lucas Ruberto (R&D Head), Martha Martorell (COO), and Francisco Massot (CTO) — supported by a Science & Tech team, a Business team, partners, and an advisor. The company is privately held, headquartered in Argentina, has participated in at least four accelerator programs between 2024 and 2026 (including GRID EXPONENTIAL, SVG Ventures, Eatable Adventures, and Agrofood BIC), and reports no public revenue disclosures or patents in the source material.

Nunatak Biotech firmographics

Firmographics
Name
Nunatak Biotech
Legal name
Nunatak Biotech
Website
https://nunatakbio.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
1–10 employees
Short description
Nunatak Biotech is an Argentine biotech startup that develops microbial bioinputs derived from Antarctic extremophiles to improve crop performance under abiotic stress, serving agribusinesses, farmers, and land restoration projects through pilot-stage field sales.
Ownership category
akta.pro rank

Nunatak Biotech industry classification

Industry
Product category
Agricultural Biologicals
NAICS
Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253), Pesticide and Other Agricultural Chemical Manufacturing (32532)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYAFABAEAK
Biostimulants & Plant Health Biologicals (Microbial/Non-microbial)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
SECONDARYIMAEAEAG
Biofertilizers & Microbial Inoculants
SECONDARYAFABAEAM
Biological Formulation, Fermentation & Scale-Up Manufacturing
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)

Keywords

  • Agricultural biological inputs
  • Microbial seed treatments
  • Soil restoration solutions
  • Abiotic stress management
  • Biofertilizer products

Where Nunatak Biotech is headquartered

Location

Headquarters

HQ city
Buenos Aires
HQ country
Argentina
HQ region
Latin America

Offices1 record

Markets served

Nunatak Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Biological Seed Treatments: Sale of microbial seed treatment products (Yamana Cold, Yamana Terra) to farmers and agribusiness companies for improving crop establishment and performance under stress conditions. Products are sold as liquid seed treatments with low-dose efficiency.
  2. Bioinputs for Land Restoration: Sale of biological solutions for land restoration and remediation projects targeting degraded soils and long-term soil-plant health rebuilding.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Nunatak Biotech product offering

Product offering

Core offering

Nunatak Biotech develops and manufactures biological agricultural inputs (biofertilizers, biostimulants, and microbial seed treatments) derived from extremophile microorganisms sourced from Antarctica and other extreme environments. The company's products, marketed under the YAMANA brand, combine microbial consortia with micronutrition and organic amendments to improve crop tolerance to abiotic stresses such as cold, salinity, and soil degradation.

Product overview

Nunatak Biotech offers a platform-based approach to biological solutions for agriculture and land restoration. Their flagship product line YAMANA includes YAMANA (core biological enhancer for crop establishment with triple-action mechanism: microbial consortium, micronutrition, and organic amendment), YAMANA Cold (microbial seed treatment for cold stress tolerance using Pseudomonas fluorescens NB1 isolated from Antarctica), and the upcoming Yamana Terra (biological solution for plant establishment in saline soils). All products leverage extremophile microorganisms from extreme environments to improve plant tolerance to abiotic stress.

Differentiator

Problem solved

Functional benefit

Brands

  • Yamana: First biological enhancer product from Nunatak's platform designed for yield improvement and crop establishment. Includes Yamana Cold - a microbial seed treatment formulated with Pseudomonas fluorescens NB1 for cold stress conditions.
  • Yamana Cold
  • Yamana Terra

Products and services

  • YAMANA YAMANA is a biological enhancer for crop establishment with a triple-action mechanism combining a microbial consortium, micronutrition, and an organic regenerator (amendment). It functions as both a biofertilizer and biostimulant, with modes of action including biological nitrogen fixation, phosphate solubilization, biofilm formation, and biocontrol of fungal phytopathogens. Target crops include wheat, barley, soybean, and pastures. Sold to agribusinesses and farmers.
  • YAMANA Cold YAMANA Cold is a microbial seed treatment formulated with Pseudomonas fluorescens NB1, a native strain isolated from Antarctica naturally adapted to thrive under cold stress. Applied before sowing, it promotes uniform germination and early crop establishment under low-temperature conditions, supporting soybean, wheat, corn, and potato crops. Fully stackable with chemical seed treatments and compatible with selected biological inputs. Sold to agribusinesses and farmers.

Quantifiable outcome

  • 50% of irrigated land becomes salinized
  • +2 more outcomes

Companies that use Nunatak Biotech

Customer profile

Segments3 records

Ideal customer profiles3 records

Nunatak Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature5 records

Nunatak Biotech partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • AcceleratorscoreOthersNunatak collaborates with accelerators as part of their ecosystem, having been selected by leading agrifood and climate innovation programs. They participated in 236+ international programs and accelerators.
  • Corporate PartnerscoreStrategic or Co-development PartnerCorporate partners collaborating with Nunatak in their ecosystem to transform agriculture and restore soils through biological solutions.
  • Innovation HubscoreStrategic or Co-development PartnerInnovation hubs part of Nunatak's collaborative ecosystem for transforming agriculture and developing biological solutions.
  • Research InstitutionscoreStrategic or Co-development PartnerResearch institutions collaborating with Nunatak, supporting the scientific foundation of their extreme microbiome platform and product development.
  • WeInvest and Emprendedoras LACminorGTM or Marketing PartnerAccelerators that organized the event in Buenos Aires where Nunatak (along with EYWA and Cromodata) presented their ventures, aiming to bridge gender gaps in Latin America's venture capital ecosystem.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Nunatak Biotech competitors and assessment

Company assessment

Direct peers

  • Puna Bio: Argentine biotech developing extremophile (including Andean/Atacama-derived) microbial biofertilizers for stressed soils. Closest direct comparable to Nunatak: same Argentine origin, same extremophile-to-agriculture thesis, same broad-acre row crop focus.
  • Symborg: Spanish manufacturer of microbial biofertilizers and biostimulants (e.g., Mycoshell, Trichoderma-based products). Closely comparable in product category (microbial biostimulants/biofertilizers) and go-to-market (partner-driven distribution to agribusiness), though larger and more global.
  • Indigo Ag: US-based ag biotech commercializing microbial seed treatments and biostimulants (e.g., Indigo's biotrinsic portfolio) targeted at row crops. Directly competes in the microbial seed treatment category that YAMANA Cold targets.
  • Pivot Bio: US-based microbial nitrogen-fixation company whose products (ProveN, ProveN 40, ReturN) overlap with the biofertilizer/biostimulant mechanism of YAMANA. Comparable in targeting row crops with a microbial mode of action that supplements or replaces conventional nitrogen inputs.
  • AgBiome: US-based biological crop protection and input company using microbial discovery to develop agricultural products (e.g., Howler fungicide, AgBiomeLabs). Comparable as a microbial-discovery platform turned product company, with a similar biological-input go-to-market.
  • Sound Agriculture: US-based company developing microbial and on-demand nutrient solutions for row crops. Comparable in product category (microbial + nutrient combination) and target customer (broad-acre agribusiness growers).
  • BioConsortia: US-based microbial discovery and product company developing seed treatments and in-furrow biologicals. Comparable as a microbial-consortium platform company focused on row crop biological inputs.
  • Locus Agricultural Solutions: US-based producer of microbial soil and seed treatments (e.g., Rhizo-L, Fungi-Act) targeting broad-acre crops. Comparable in offering microbial-based biological inputs and in working with agribusiness distribution channels.

Broad incumbents

  • Bioceres: Argentina-based agricultural biotechnology company with biological-input adjacencies (including Rizobacter) and trait platforms (HB4). Larger incumbent that competes for the same Argentine/LATAM agribusiness customer base and validates the market for biological inputs in the region.
  • Novonesis (formerly Novozymes): Global microbial and enzyme powerhouse with a dedicated agriculture biological-input business. Broad incumbent in the same product category; does not specialize in extremophile-sourced consortia but sets the pricing and channel benchmark for microbial ag inputs.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Nunatak Biotech social profiles

Digital presence

Nunatak Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nunatak Biotech leadership team

Management profile

Number of profiles

Profiles5 records

Nunatak Biotech funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nunatak Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nunatak Biotech

What does Nunatak Biotech do?

Nunatak Biotech develops and manufactures biological agricultural inputs (biofertilizers, biostimulants, and microbial seed treatments) derived from extremophile microorganisms sourced from Antarctica and other extreme environments. The company's products, marketed under the YAMANA brand, combine microbial consortia with micronutrition and organic amendments to improve crop tolerance to abiotic stresses such as cold, salinity, and soil degradation.

Is Nunatak Biotech a public or private company?

Nunatak Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Nunatak Biotech founded?

Nunatak Biotech was founded in 2023. It employs 1 to 10 people.

Where is Nunatak Biotech based?

Nunatak Biotech is headquartered in Buenos Aires, Argentina, in the Latin America region.

How does Nunatak Biotech make money?

Two revenue lines are on record. Biological Seed Treatments are the primary driver. The others are bioinputs for Land Restoration.

Who are Nunatak Biotech's main competitors?

Direct peers on record are Puna Bio, Symborg, Indigo Ag, Pivot Bio, AgBiome, Sound Agriculture, BioConsortia and Locus Agricultural Solutions. Broad incumbents are Bioceres and Novonesis (formerly Novozymes).

Does Nunatak Biotech have an API?

No public API is recorded for Nunatak Biotech.

What industry is Nunatak Biotech in?

Nunatak Biotech's product category is Agricultural Biologicals. Its primary akta.pro industry code is AFABAEAK, Biostimulants & Plant Health Biologicals (Microbial/Non-microbial), with a secondary code of IMAEAEAG, Biofertilizers & Microbial Inoculants. Its NAICS code is 3253 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
LA NACIONDescubren microorganismos extremos que tienen la respuesta para que los cultivos rindan másArgentine agtech company Nunatak is preparing to launch Yamana Cold, a biological seed treatment derived from extremophile microorganisms, for the 2026 soybean campaign after receiving Senasa approval. The product has demonstrated yield increases of up to 4% in wheat and soybean trials by enhancing crop resilience against abiotic stress factors such as cold and salinity. The company plans to expand its distribution network across Argentina while developing additional solutions using its proprietary library of over 1,200 microbial strains.Protein ReportAgrofoodBIC invests in Argentine bioinputs startup NunatakAgrofoodBIC invested in Argentine bioinputs startup Nunatak, developed by Eatable Adventures, targeting soil degradation and fertilizer efficiency. Nunatak's technology uses extremophile microorganisms, and its first product YAMANA is in commercial stage. AgrofoodBIC's partners include Granarolo and the University of Bologna.EatableadventuresAgrofoodBIC enters the capital of Nunatak, an Eatable Adventures portfolio startup developing next-generation bioinputsAgrofoodBIC invested in Nunatak, an Argentine startup developing microbiological bioinputs to address soil degradation and climate challenges. The startup's technology, inspired by extremophile microorganisms, aims to improve crop nutrition and resilience. Nunatak has registered its first product, YAMANA, and is in the commercial stage.